Question follow-through · 21388
Mental Health: Cannabis
To ask the Secretary of State for Health and Social Care, what assessment she has made of the effectiveness of regulations for the private prescription of medical cannabis at protecting patients with severe mental health conditions.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 28 Aug 2026
- Target answer date
- 2 Sept 2026
- Answer
- 9 Sept 2026 · 12 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
28 Aug 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what assessment she has made of the effectiveness of regulations for the private prescription of medical cannabis at protecting patients with severe mental health conditions.
2 Sept 2026
Target answer date
Date supplied by the official written-questions record.
9 Sept 2026
Answer published
The Care Quality Commission (CQC) is the independent regulator of health and adult social care services in England, including private clinics that prescribe cannabis-based products for medicinal use (CBPMs). Private providers must be registered with the C...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.